Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.625
Bid: 1.60
Ask: 1.65
Change: 0.025 (1.56%)
Spread: 0.05 (3.125%)
Open: 1.60
High: 1.675
Low: 1.60
Prev. Close: 1.60
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results

Mon, 19th Apr 2021 11:32

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

----------

AIM - WINNERS

----------

Advance Energy PLC, nine times higher at 2.4 pence, 12-month range 0.1p-2.57p. Completes acquisition of an interest in the Buffalo PSC, offshore Timor-Leste. Advance Energy raises GBP21.8 million via 840.1 million share placing at 2.6p per share.

----------

Genedrive PLC, up 74.5p, 12-month range 38.33p-302.60p. The molecular diagnostics firm says it has been successful with its tender into Public Health England under Lot 1 of the National Microbiology Framework. Genedrive says award of a framework contract is not exclusive to the company, nor a guarantee of orders, but it does allow participating authorities to issue call-off orders for products in the future.

----------

D4T4 Solutions PLC, up 9.6% at 350p, 12-month range 160.75p-350p. Following strong second half to the financial year, revenue and adjusted pretax profit expected to be GBP22.8 million and GBP4.2 million respectively, both ahead of the board's prior expectations. "This is a very pleasing result and bears out the confidence we placed in the strength of the pipeline of business opportunities carried into the second half of the year," the data management platform says.

----------

AIM - LOSERS

----------

Pantheon Resources PLC, down 46% at 21.5p, 12-month range 12.35p-48.58p. The oil and gas exploration company says operations at Talitha A well on the Alaska North Slope concluded and suspended for future testing operations. Pantheon Resources says Kuparuk section of well proved more geologically complex than expected. Says it now intends to recommence its farmout strategy to attract a suitable partner to best exploit the Kuparuk across Pantheon's acreage. "Today's news is a tale of two stories. We are of course disappointed not to deliver the high tested flow rates we were hoping for from the Kuparuk. We will continue our analysis of this complex zone as we believe it still offers great potential for our company," says Chief Executive Officer Jay Cheatham.

----------

Purplebricks Group PLC, down 4.0% at 105.60p, 12-month range 31.11p-112.77p. UBS double downgrades online estate agent to Sell from Buy.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 Apr 2018 12:56

Genedrive To Unveil Hepatitis C ID Kit In Singapore Exhibition

LONDON (Alliance News) - Molecular diagnostics firm Genedrive PLC said Tuesday it is to premiere its hepatitis C ID kit in the Asia Pacific at an in will

Read more
20 Mar 2018 13:59

Genedrive Confident For Future As Interim Loss Narrows On Lower Costs

LONDON (Alliance News) - Genedrive PLC said on Tuesday that its pretax loss narrowed in the first half of the financial year as financing costs reduced for six months to the a

Read more
13 Mar 2018 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 14 March PrudentialFull Year ResultsDignityFull Year MacdonaldHalf 15

Read more
27 Jan 2017 09:42

Genedrive's revenues rise despite difficulties in India

(ShareCast News) - Genedrive, an AIM listed near patient molecular diagnostics diagnostics company, has progressed well in the second half despite difficulties faced with its Tuberculosis (TB) assay in India. Group revenues "significantly" rose to £2.8m for six months ended 31 December 2016, up f

Read more
16 Jan 2017 16:11

Genedrive supplies field test units to US DoD

(ShareCast News) - Manchester-based diagnostics company genedrive announced on Monday that it has supplied Genedrive units and assays to the United States Department of Defense for field trials, as part its $7.8m development programme for a handheld device to allow for the detection of biohazards su

Read more
17 Nov 2016 09:53

Genedrive Human Genotyping Test Gets EU Certification

Read more
11 Oct 2016 14:05

Genedrive's revenue rises while it re-focuses company

(ShareCast News) - AIM-listed molecular diagnostics company Genedrive's revenue grew as it re-focused to concentrate on its Genedrive platform, launched a new test in India and changed its name. For the year ended 30 June, the company, formerly Epistem, reported 12% growth in turnover to £5.1m, comp

Read more
11 Oct 2016 13:11

CORRECT: Genedrive Loss Widens As Product Sales Slow To Materialise

Read more
21 Sep 2016 08:43

Genedrive appoints Matthew Fowler CFO

(ShareCast News) - AIM-listed molecular diagnostic company Genedrive appointed Matthew Fowler as chief financial officer and a member of the board. He will start at a date to be confirmed shortly and will replace John Rylands who has been with company since 2002. Fowler joins Gendrive from Scapa Gr

Read more
2 Aug 2016 09:19

Genedrive Sees Strong Revenue Increase But Wider Annual Loss

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.